TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32967513

Group type: EXPERIMENTAL
Intervention: Personalized psychological interventions, routine nursing care and drug treatment
Number of subjects: 438

Group type: COMPARATOR
Intervention: Routine nursing care and drug treatment
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Both groups (observation and control)
Number of subjects: 438
Study: 35337884

Group type: EXPERIMENTAL
Intervention: Cooking/Serving Resources and Meal Delivery
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Cooking/Serving Resources
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Meal Delivery
Number of subjects: 499
Study: 34758385

Group type: EXPERIMENTAL
Intervention: Precoding
Number of subjects: 1205
Study: 35263346

Group type: EXPERIMENTAL
Intervention: 10 minute therapy dog team visit in addition to usual care
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no therapy dog visit)
Number of subjects: 97
Study: 37019580

Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin with ezetimibe combination therapy
Number of subjects: 3780

Group type: COMPARATOR
Intervention: High-intensity statin monotherapy
Number of subjects: 3780
Study: 36241842

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus fluorouracil and cisplatin (FP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blended chemotherapy (including FP, carboplatin plus paclitaxel, FOLFOX, FOLFIRI, docetaxel plus FP, trastuzumab plus FP, and trastuzumab plus FOLFOX)
Number of subjects: 0
Study: 32217842

Group type: EXPERIMENTAL
Intervention: Resilient Hyaluronic Acid Fillers
Number of subjects: 174

Group type: COMPARATOR
Intervention: Comparator HA filler
Number of subjects: 174
Study: 34962457

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 2 weeks for 24 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (every 2 weeks for 24 weeks)
Number of subjects: 60
Study: 34418716

Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bilateral vapocoolant spray
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Unilateral vapocoolant spray
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (routine digital block process)
Number of subjects: 100
Study: 33460301

Group type: EXPERIMENTAL
Intervention: Ibudilast treatment
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo treatment (control)
Number of subjects: 255
Study: 35390320

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 80
Study: 34022170

Group type: COMPARATOR
Intervention: Pooled population-based studies (no antiplatelet therapy)
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Lobar ICH
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Lobar ICH without AF
Number of subjects: 674
Study: 32833763

Group type: EXPERIMENTAL
Intervention: 3D display technique
Number of subjects: 128
Study: 35349397

Group type: EXPERIMENTAL
Intervention: Balanced solution (Plasma‐Lyte 148)
Number of subjects: 10520

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 10520
Study: 32918078

Group type: EXPERIMENTAL
Intervention: 8 half-hour telephone sessions (n = 162)
Number of subjects: 322

Group type: COMPARATOR
Intervention: newsletter control (n = 160)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 322
Study: 35971295

Group type: EXPERIMENTAL
Intervention: Active HF-rTMS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham HF-rTMS
Number of subjects: 80
Study: 35436797

Group type: EXPERIMENTAL
Intervention: Selective, clopidogrel-based therapy (unguided de-escalation)
Number of subjects: 11006

Group type: EXPERIMENTAL
Intervention: Selective, clopidogrel-based therapy (guided clopidogrel therapy)
Number of subjects: 11006

Group type: EXPERIMENTAL
Intervention: Selective, clopidogrel-based therapy (overall)
Number of subjects: 11006

Group type: COMPARATOR
Intervention: Conventional treatment (ticagrelor or prasugrel)
Number of subjects: 11006
Study: 32285142

Group type: EXPERIMENTAL
Intervention: Levofloxacin + dexamethasone sodium phosphate (L-DSP) eye drops
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Levofloxacin (L) eye drops
Number of subjects: 125

Group type: COMPARATOR
Intervention: Dexamethasone sodium phosphate (DSP) eye drops
Number of subjects: 125
Study: 33772862

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) initiated within 30 days of diagnosis
Number of subjects: 16
Study: 32305105

Group type: EXPERIMENTAL
Intervention: Reverse shoulder arthroplasty with latissimus dorsi and teres major tendon transfer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reverse shoulder arthroplasty without tendon transfer
Number of subjects: 0
Study: 35534184

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (cumulative dose 72.5 mg/kg)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 372
Study: 34404384

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 mcg/kg intravenous
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 mcg/kg intravenous
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 24
Study: 32924076

Group type: EXPERIMENTAL
Intervention: Acute psychological stress induced by displaying a brief stressful movie clip
Number of subjects: 88

Group type: COMPARATOR
Intervention: Neutral movie clip
Number of subjects: 88
Study: 34195809

Group type: EXPERIMENTAL
Intervention: Rule-out profile based on the 0/1-h high-sensitivity cardiac troponin T protocol (<5 ng/L or ≤12 ng/L and a change of <3 ng/L at 1-h)
Number of subjects: 1638

Group type: EXPERIMENTAL
Intervention: Addition of clinical risk scores (TIMI, HEART, EDACS) to the rule-out profile
Number of subjects: 1638
Study: 33362221

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements with 50% milk protein
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements with 20% milk protein in CSB
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Soy isolate over dehulled soy
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Lipid-based nutrient supplements (LNS) vs Corn-soy blends (CSB)
Number of subjects: 1609
Study: 36008814

Group type: EXPERIMENTAL
Intervention: Pegloticase + methotrexate (15 mg/week) and folic acid (1 mg/day) administered 4 weeks before and during pegloticase therapy.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pegloticase + methotrexate
Number of subjects: 14
Study: 35162891

Group type: EXPERIMENTAL
Intervention: Acupressure on the Shenmen and Neiguan acupoints
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular routine care
Number of subjects: 100
Study: 32943236

Group type: EXPERIMENTAL
Intervention: Neck dissection (ND)
Number of subjects: 105
Study: 35848358

Group type: EXPERIMENTAL
Intervention: Standard (ST) preoperative chemotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Histotype-tailored (HT) preoperative chemotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Standard (S) chemotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Histotype-tailored (HT) chemotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: CINSARC scoring
Number of subjects: 86
Study: 34449183

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 1426

Group type: COMPARATOR
Intervention: Vitamin K Antagonists
Number of subjects: 1426
Study: 33719265

Group type: EXPERIMENTAL
Intervention: 120 mmHg (group L)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 180 mmHg (group H)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 0 mmHg (group C)
Number of subjects: 27
Study: 35524184

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 33252985

Group type: EXPERIMENTAL
Intervention: BGF 320 (320/18/9.6 μg)
Number of subjects: 8509

Group type: EXPERIMENTAL
Intervention: BGF 160 (160/18/9.6 μg)
Number of subjects: 8509

Group type: COMPARATOR
Intervention: GFF (18/9.6 μg)
Number of subjects: 8509

Group type: COMPARATOR
Intervention: BFF (320/9.6 μg)
Number of subjects: 8509
Study: 35050796

Group type: EXPERIMENTAL
Intervention: Apnea training (5 maximal static apneas daily for 6 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Apnea training
Number of subjects: 22
Study: 33745107

Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation (TPNS)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Deferred therapy (control)
Number of subjects: 151
Study: 32212314

Group type: EXPERIMENTAL
Intervention: Myriocin exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clone LH03
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-driven adaptive laboratory evolution (ALE)
Number of subjects: 0
Study: 35760762

Group type: EXPERIMENTAL
Intervention: Low Load Eccentric Exercise (LL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High Load Eccentric Exercise with Blood Flow Restriction (HL-BFR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High Load Eccentric Exercise (HL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low Load Eccentric Exercise with Blood Flow Restriction (LL-BFR)
Number of subjects: 60
Study: 34213860

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) for 2 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Psychoeducation and resting (PER)
Number of subjects: 38
Study: 36426763

Group type: EXPERIMENTAL
Intervention: Radio-Taiso exercise program (3-5 min sessions, 1-4 times per day for 12 weeks)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Radio-Taiso exercise program
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 58
Study: 33651027

Group type: COMPARATOR
Intervention: Effervescent tablet (ET)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Chitosan solution (CH)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Chitosan nanoparticle solution (CN)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Control solution (WC)
Number of subjects: 344
Study: 32060217

Group type: EXPERIMENTAL
Intervention: dPET
Number of subjects: 66

Group type: COMPARATOR
Intervention: cPET
Number of subjects: 66
Study: 35667775

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L crosswalk
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: ReQoL-UI
Number of subjects: 361

Group type: COMPARATOR
Intervention: Complete case ReQoL-UI baseline-adjusted QALYs
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Multiple-imputation EQ-5D-5L crosswalk unadjusted QALYs
Number of subjects: 361

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 361
Study: 33641272

Group type: EXPERIMENTAL
Intervention: DSE + MET (n=41)
Number of subjects: 125

Group type: COMPARATOR
Intervention: DSE alone (n=39)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Conventional physiotherapy (n=45)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Functional disability
Number of subjects: 125
Study: 35777128

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Relapse Prevention-Cognitive Behavioral Therapy (CBT-RP)
Number of subjects: 136
Study: 32634046

Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best-in-class drug-eluting stents (DES)
Number of subjects: 0
Study: 35835136

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Punch biopsy (regular care)
Number of subjects: 598
Study: 33809346

Group type: EXPERIMENTAL
Intervention: GA with SPI-guided FNT administration
Number of subjects: 176

Group type: COMPARATOR
Intervention: Preventive topical 2% proparacaine (TA)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Preprocedural peribulbar block (PBB) using 0.5% bupivacaine with 2% lidocaine
Number of subjects: 176

Group type: COMPARATOR
Intervention: Preprocedural intravenous infusion of 1.0 g of metamizole (M)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Preprocedural intravenous infusion of 1.0 g of paracetamol (P)
Number of subjects: 176
Study: 32615575

Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 500
Study: 35707478

Group type: EXPERIMENTAL
Intervention: Acupressure on points Ren3, Ren4, Liv3, Sp6, and Sp10
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 96
Study: 33573600

Group type: EXPERIMENTAL
Intervention: Global procedure
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sequential procedure
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 9
Study: 32513312

Group type: EXPERIMENTAL
Intervention: Transgenic Camelina sativa seed oil (CSO) 450 mg/d EPA + DHA for 8 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fish oil (FO) 450 mg/d EPA + DHA for 8 weeks
Number of subjects: 31
Study: 35476192

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) and communication intervention during the procedure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (routine surgical treatment)
Number of subjects: 100
Study: 32223344

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 20
Study: 34476452

Group type: EXPERIMENTAL
Intervention: Toothpaste containing emulsifier 30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoride toothpaste containing sodium lauryl sulfate (SLS) surfactant
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both toothpaste types
Number of subjects: 60
Study: 32845864

Group type: EXPERIMENTAL
Intervention: Myrtus communis fruits (powdered)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tranexamic acid
Number of subjects: 40
Study: 35354339

Group type: EXPERIMENTAL
Intervention: Emulsion cream containing 0.05% APP in triglycerides (APP preparation)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mineral oil hydrocarbon (petrolatum)-based skin cream (MHB preparation)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both APP and MHB preparations
Number of subjects: 54
Study: 34125080

Group type: EXPERIMENTAL
Intervention: Individualized PEEP guided by minimum driving pressure
Number of subjects: 148

Group type: COMPARATOR
Intervention: Fixed PEEP of 6 cm H2O
Number of subjects: 148
Study: 32633762

Group type: EXPERIMENTAL
Intervention: Health care exposures before hospital admission for sepsis
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Outpatient encounters in the 7 days before admission
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Medical treatment in the 30 days before admission
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Identification of sepsis-associated pathogens
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Underlying comorbidities and 30-day mortality
Number of subjects: 1078
Study: 35807851

Group type: EXPERIMENTAL
Intervention: Isocaloric dietary protein restriction (PR; n = 10, diet of 8409 2360 KJ per day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Caloric restriction (CR; n = 11, diet of 5941 686 KJ per day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isocaloric dietary protein restriction (PR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 21
Study: 34238100

Group type: EXPERIMENTAL
Intervention: Patient-led follow-up (education and self-referral to project nurse)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Standard follow-up (routine clinical doctor visits)
Number of subjects: 512
Study: 32653726

Group type: EXPERIMENTAL
Intervention: Pneumococcal isolates
Number of subjects: 537
Study: 34274366

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) on, tidal volume (TV) at 3-4 mL.kg-1 (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) on, tidal volume (TV) at 3-4 mL.kg-1, PEEP at 5 cmH2O (Group 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mechanical ventilation off (Group 1)
Number of subjects: 60
Study: 33449169

Group type: EXPERIMENTAL
Intervention: 12-week physical activity (PA) intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 16
Study: 32575919

Group type: EXPERIMENTAL
Intervention: Gamified experimental group
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 127
Study: 35512392

Group type: EXPERIMENTAL
Intervention: Deceptive Placebo
Number of subjects: 201

Group type: COMPARATOR
Intervention: Open Placebo
Number of subjects: 201

Group type: COMPARATOR
Intervention: No Placebo
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Beliefs about pharmaceuticals
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Perceived sensitivity to medicines
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Concerns about Modafinil
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Negative affectivity
Number of subjects: 201
Study: 32297822

Group type: EXPERIMENTAL
Intervention: Bioactive cement (ACTIVA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glass ionomer cement (GIC; Ketac Cem)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Resin luting agent (Nexus 3)
Number of subjects: 30
Study: 34516459

Group type: EXPERIMENTAL
Intervention: Fluconazole 200 mg daily for 3 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 34171518

Group type: EXPERIMENTAL
Intervention: TENSE training program (three-day training course and two follow-up sessions)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 297
Study: 32479206

Group type: EXPERIMENTAL
Intervention: Cultivars with varying resistance levels to RLNs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultivars with equivalent exposures to presowing and postharvest RLN densities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed design and analysis approach
Number of subjects: 0
Study: 36153016

Group type: EXPERIMENTAL
Intervention: Motion control shoes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neutral shoes
Number of subjects: 40
Study: 34344633

Group type: EXPERIMENTAL
Intervention: Virtual classroom session on Second Life®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional face-to-face classroom session
Number of subjects: 0
Study: 34657193

Group type: EXPERIMENTAL
Intervention: Same-day preparation with Sodium Picosulfate/Magnesium Citrate (SPMC)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Split-dose preparation with Sodium Picosulfate/Magnesium Citrate (SPMC)
Number of subjects: 197
Study: 33277698

Group type: EXPERIMENTAL
Intervention: Mulberry leaf DNJ (MLD) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment (CG)
Number of subjects: 0
Study: 32740593

Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy malfunction
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy duration longer than 10 days
Number of subjects: 91
Study: 32424421

Group type: EXPERIMENTAL
Intervention: New biomarkers for treatment selection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard biomarkers for treatment selection
Number of subjects: 0
Study: 33691344

Group type: EXPERIMENTAL
Intervention: Clarithromycin-based bismuth-containing quadruple therapy (C-BQT)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Furazolidone-based bismuth-containing quadruple therapy (F-BQT)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Cumulative eradication rates of C-F group
Number of subjects: 350

Group type: COMPARATOR
Intervention: Cumulative eradication rates of F-C group
Number of subjects: 350
Study: 32580666

Group type: EXPERIMENTAL
Intervention: Endurance training (3 months, 3 times per week)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Muscle training (3 months, 3 times per week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 45
Study: 32826832

Group type: EXPERIMENTAL
Intervention: 24-hour recovery trial
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 48-hour recovery trial
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both recovery periods
Number of subjects: 10

Group type: COMPARATOR
Intervention: Beach volleyball drills and match performance
Number of subjects: 10
Study: 32114925

Group type: EXPERIMENTAL
Intervention: Hadamard-coded modulation (HCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DC-reduced HCM (DCR-HCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple lamps transmitting the same data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spatial distribution of maximum throughput
Number of subjects: 0
Study: 35713224

Group type: EXPERIMENTAL
Intervention: AI group (n = 16)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: AIHC group (n = 17)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (CG; n = 20)
Number of subjects: 53
Study: 33358848

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) or medication
Number of subjects: 0
Study: 32791313

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with a conditioning-test paired-pulse paradigm, applying the conditioning stimulus to the right primary motor cortex and the test stimulus to the left primary motor cortex.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) measuring latency distribution of transcallosal fibers.
Number of subjects: 0
Study: 34799776

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with 2 J red laser and 3 J infrared laser on 21 points on the tongue
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo group (simulated PBMT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 112
Study: 34321035

Group type: EXPERIMENTAL
Intervention: Robot-based gamified exercise platform
Number of subjects: 24

Group type: COMPARATOR
Intervention: Computer-based configuration (no robot)
Number of subjects: 24